A citation-based method for searching scientific literature

Kristyna Tomasova, Andrea Cumova, Karolina Seborova, Josef Horak, Kamila Koucka, Ludmila Vodickova, Radka Vaclavikova, Pavel Vodicka. Cancers (Basel) 2020
Times Cited: 6







List of co-cited articles
13 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer.
John M Carethers, Barbara H Jung. Gastroenterology 2015
211
33

DNA mismatch repair and the DNA damage response.
Zhongdao Li, Alexander H Pearlman, Peggy Hsieh. DNA Repair (Amst) 2016
114
33

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
33

Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis.
Meichen Yin, Jiayu Shen, Shuqian Yu, Jing Fei, Xiaoqing Zhu, Jiayao Zhao, Lingyun Zhai, Annapurna Sadhukhan, Jianwei Zhou. Onco Targets Ther 2019
26
33

A single-cell landscape of high-grade serous ovarian cancer.
Benjamin Izar, Itay Tirosh, Elizabeth H Stover, Isaac Wakiro, Michael S Cuoco, Idan Alter, Christopher Rodman, Rachel Leeson, Mei-Ju Su, Parin Shah,[...]. Nat Med 2020
43
33

Tumor-Host Cell Interactions in Ovarian Cancer: Pathways to Therapy Failure.
Elke Pogge von Strandmann, Silke Reinartz, Uwe Wager, Rolf Müller. Trends Cancer 2017
47
33

Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer.
Jieru Zhou, Xiaoduan Li, Xiaoli Wu, Ting Zhang, Qinyi Zhu, Xinjing Wang, Husheng Wang, Kai Wang, Yingying Lin, Xipeng Wang. Cancer Immunol Res 2018
100
33

Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype.
Xin Chen, Jieru Zhou, Xiaoduan Li, Xinjing Wang, Yingying Lin, Xipeng Wang. Cancer Lett 2018
95
33

Non-coding RNA networks in cancer.
Eleni Anastasiadou, Leni S Jacob, Frank J Slack. Nat Rev Cancer 2018
555
33

Immune System and DNA Repair Defects in Ovarian Cancer: Implications for Locoregional Approaches.
Alberto Farolfi, Giorgia Gurioli, Paola Fugazzola, Salvatore Luca Burgio, Claudia Casanova, Giorgia Ravaglia, Amelia Altavilla, Matteo Costantini, Andrea Amadori, Massimo Framarini,[...]. Int J Mol Sci 2019
10
33

Immunotherapy in ovarian cancer.
K Odunsi. Ann Oncol 2017
92
33

Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.
Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda, Manabu Minami, Atsushi Kawaguchi, Toshinori Murayama, Masashi Kanai, Yukiko Mori, Shigemi Matsumoto, Shunsuke Chikuma,[...]. J Clin Oncol 2015
578
33



Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
Hidewaki Nakagawa, Janet C Lockman, Wendy L Frankel, Heather Hampel, Kelle Steenblock, Lawrence J Burgart, Stephen N Thibodeau, Albert de la Chapelle. Cancer Res 2004
112
16

Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients.
Andrea Mann, Estrid Hogdall, Susan J Ramus, Richard A DiCioccio, Claus Hogdall, Lydia Quaye, Valerie McGuire, Alice S Whittemore, Mitul Shah, David Greenberg,[...]. Eur J Cancer 2008
19
16

Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients.
Eva Dreussi, Erika Cecchin, Jerry Polesel, Vincenzo Canzonieri, Marco Agostini, Caterina Boso, Claudio Belluco, Angela Buonadonna, Sara Lonardi, Francesca Bergamo,[...]. Int J Mol Sci 2016
9
16


Conserved properties between functionally distinct MutS homologs in yeast.
P Pochart, D Woltering, N M Hollingsworth. J Biol Chem 1997
99
16

Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2.
Mario E Beiner, Barry Rosen, Anthony Fyles, Ian Harley, Tuya Pal, Kathy Siminovitch, Shiyu Zhang, Ping Sun, Steven A Narod. Cancer Epidemiol Biomarkers Prev 2006
35
16

Interactions of DNA repair gene variants modulate chromosomal aberrations in healthy subjects.
Pavel Vodicka, Ludovit Musak, Christoph Frank, Alena Kazimirova, Veronika Vymetalkova, Magdalena Barancokova, Bozena Smolkova, Zuzana Dzupinkova, Katerina Jiraskova, Sona Vodenkova,[...]. Carcinogenesis 2015
19
16

DNA mismatch repair in cancer.
Marina Baretti, Dung T Le. Pharmacol Ther 2018
90
16


MLH1-93G > A is a risk factor for MSI colorectal cancer.
Nicola Whiffin, Peter Broderick, Steven J Lubbe, Alan M Pittman, Steven Penegar, Ian Chandler, Richard S Houlston. Carcinogenesis 2011
28
16

Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
John P Geisler, Michael J Goodheart, Anil K Sood, Richard J Holmes, Melanie A Hatterman-Zogg, Richard E Buller. Cancer 2003
78
16

Mismatch repair polymorphisms and the risk of colorectal cancer.
Sonja I Berndt, Elizabeth A Platz, M Daniele Fallin, Lucy W Thuita, Sandra C Hoffman, Kathy J Helzlsouer. Int J Cancer 2007
46
16

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Susan J Ramus, Honglin Song, Ed Dicks, Jonathan P Tyrer, Adam N Rosenthal, Maria P Intermaggio, Lindsay Fraser, Aleksandra Gentry-Maharaj, Jane Hayward, Susan Philpott,[...]. J Natl Cancer Inst 2015
201
16



A MLH1 polymorphism that increases cancer risk is associated with better outcome in sporadic colorectal cancer.
Nargisse Nejda, Daniel Iglesias, Mariano Moreno Azcoita, Vicente Medina Arana, Juan J González-Aguilera, Antonia M Fernández-Peralta. Cancer Genet Cytogenet 2009
20
16

MSH4 acts in conjunction with MLH1 during mammalian meiosis.
S Santucci-Darmanin, D Walpita, F Lespinasse, C Desnuelle, T Ashley, V Paquis-Flucklinger. FASEB J 2000
104
16


Common 5p15.33 and 6p21.33 variants influence lung cancer risk.
Yufei Wang, Peter Broderick, Emily Webb, Xifeng Wu, Jayaram Vijayakrishnan, Athena Matakidou, Mobshra Qureshi, Qiong Dong, Xiangjun Gu, Wei Vivien Chen,[...]. Nat Genet 2008
416
16

MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.
Jee Hyun Park, Nung Soo Kim, Jae Yong Park, Yee Soo Chae, Jong Gwang Kim, Sang Kyun Sohn, Joon Ho Moon, Byung Woog Kang, Hun Mo Ryoo, Sung Hwa Bae,[...]. J Cancer Res Clin Oncol 2010
18
16

The DNA-mismatch repair enzyme hMSH2 modulates UV-B-induced cell cycle arrest and apoptosis in melanoma cells.
Markus Seifert, Stefan J Scherer, Wilfried Edelmann, Markus Böhm, Viktor Meineke, Markus Löbrich, Wolfgang Tilgen, Jörg Reichrath. J Invest Dermatol 2008
18
16

HMSH2 gene alterations associated with recurrence of oral squamous cell carcinoma.
S Sanguansin, S Petmitr, P Punyarit, V Vorasubin, W Weerapradist, R Surarit. J Exp Clin Cancer Res 2006
12
16

Lung cancer and DNA repair genes: multilevel association analysis from the International Lung Cancer Consortium.
Rémi Kazma, Marie-Claude Babron, Valérie Gaborieau, Emmanuelle Génin, Paul Brennan, Rayjean J Hung, John R McLaughlin, Hans E Krokan, Maiken B Elvestad, Frank Skorpen,[...]. Carcinogenesis 2012
32
16


TEX15: A DNA repair gene associated with prostate cancer risk in Han Chinese.
Xiaoling Lin, Zhongzhong Chen, Peng Gao, Zhimei Gao, Haitao Chen, Jun Qi, Fang Liu, Dingwei Ye, Haowen Jiang, Rong Na,[...]. Prostate 2017
4
25

Correlation between polymorphisms in DNA mismatch repair genes and the risk of primary hepatocellular carcinoma for the Han population in northern China.
Ying Liu, Xiaolin Zhang, Jinhai Jia, Longmei Tang, Xia Gao, Lina Yan, Liqin Wang, Fengxue Yu, Ning Ma, Wenxuan Liu,[...]. Scand J Gastroenterol 2015
6
16

Mismatch repair single nucleotide polymorphisms and thyroid cancer susceptibility.
Luís S Santos, Susana N Silva, Octávia M Gil, Teresa C Ferreira, Edward Limbert, José Rueff. Oncol Lett 2018
6
16

DNA mismatch repair: functions and mechanisms.
Ravi R Iyer, Anna Pluciennik, Vickers Burdett, Paul L Modrich. Chem Rev 2006
588
16


Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility.
Yadav Sapkota, John R Mackey, Raymond Lai, Conrado Franco-Villalobos, Sasha Lupichuk, Paula J Robson, Karen Kopciuk, Carol E Cass, Yutaka Yasui, Sambasivarao Damaraju. PLoS One 2013
37
16

Genetic architecture of colorectal cancer.
Ulrike Peters, Stephanie Bien, Niha Zubair. Gut 2015
119
16

Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing.
Daniel Chubb, Peter Broderick, Matthew Frampton, Ben Kinnersley, Amy Sherborne, Steven Penegar, Amy Lloyd, Yussanne P Ma, Sara E Dobbins, Richard S Houlston. J Clin Oncol 2015
61
16

Role of pharmacogenetics as predictive biomarkers of response and/or toxicity in the treatment of colorectal cancer.
Shriya Bhushan, Howard McLeod, Christine M Walko. Clin Colorectal Cancer 2009
15
16

Conserved motifs of MutL proteins.
Michał Banasik, Paweł Sachadyn. Mutat Res 2014
10
16



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.